Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia-Reference-Cited by-同舟云学术

Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia

Published:2023-04 Issue: Volume:558 Page:216103
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhang Rui,Liu Qingxi,Zhou Sa,He Hongpeng,Zhao Mingfeng,Ma Wenjian^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Recent developments in immunotherapy of acute myeloid leukemia;Lichtenegger;J. Hematol. Oncol.J Hematol Oncol.,2017

2. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades;Thein;Cancer,2013

3. Cellular therapy for acute myeloid Leukemia - current status and future prospects;Hansrivijit;Blood Rev.,2019

4. Engineering CAR-T cells for next-generation cancer therapy;Hong;Cancer Cell,2020

5. Clinical lessons learned from the first leg of the CAR T cell journey;Majzner;Nat. Med.,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Siglec3-like lectin from Nile tilapia (Oreochromis niloticus): Transcriptional profiling upon Streptococcus agalactiae infection and its potential role in immune escape;Aquaculture;2024-09

2. Advances in CAR-NK cell therapy for hematological malignancies;Frontiers in Immunology;2024-06-28

3. Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies;Biological Chemistry;2024-05-21

4. Development of NK cell-based cancer immunotherapies through receptor engineering;Cellular & Molecular Immunology;2024-03-05

5. TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches;Annals of Hematology;2023-09-28